Acute Lymphoblastic Leukemia

Our pathologists, hematologists, and oncologists combine their expertise to determine the genetic characteristics of acute lymphoblastic leukemia, a fast-growing cancer of the blood and bone marrow. Together, we accurately diagnose the condition and create a personalized treatment plan, which may include chemotherapy, targeted medications, or stem cell transplantation. Throughout the treatment process and beyond, we provide supportive services to you and your loved ones.

Clinical Trials and Research Studies

Phase 5

A Phase 1/2 Open-label Study Investigating the Safety Tolerability and Efficacy of ASP7517 in subjects with Relapsed/Refractory Acute Myeloid Leukemia (AML) and Relapsed/Refractory Higher Risk Myelodysplastic Syndrome (MDS)

Learn More

Phase 2

A PHASE IB-II STUDY OF HIGH-DOSE POST-TRANSPLANT CYCLOPHOSPHAMIDE BORTEZOMIB AND ABATACEPT FOR THE PREVENTION OF GRAFT-VERSUS-HOST DISEASE (GVHD) FOLLOWING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT)

Learn More

Phase 3

A Phase 3 Randomized Multicenter Double-Blind Placebo-Controlled Efficacy and Safety Study of Birtamimab Plus Standard of Care vs. Placebo Plus Standard of Care in Mayo Stage IV Subjects with Light Chain (AL) Amyloidosis

Learn More

Phase 1

A First in Human Study of theMenin-KMT2A (MLL1)Inhibitor JNJ-75276617 in Participants with Acute Leukemia

Learn More